InduPro
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $85M
Overview
A proteomics-driven platform biotech using AI to discover novel biologic drugs against challenging disease targets.
OncologyImmunology
Technology Platform
Integrated proteomics and AI platform that maps disease-relevant protein interactions to design novel antibody and protein-based therapeutics.
Funding History
1Total raised:$85M
Series A$85M
Opportunities
Potential to unlock a new generation of biologic drugs against previously undruggable targets, creating immense value through platform validation and partnerships.
Risk Factors
Risk that its platform fails to produce clinically viable drug candidates, or that its AI models do not translate from in silico predictions to real-world biology.
Competitive Landscape
Competes with other AI-driven drug discovery platforms and large biotechs with internal proteomics capabilities to identify novel biologic drug targets.